Oliver was a co-founder of Biognosys in 2008 and is leading the company as CEO, starting as a spin-off from ETH Zurich to a market-leading inventor and provider of proteomics technology that Biognosys is today.
Kristina Beeler, PhD
Chief Product Development & Marketing Officer
Kristina leads Biognosys' product development and marketing efforts, driving innovation and growth. With her expertise in business development and marketing, she spearheads the creation of cutting-edge research services offering that address the evolving needs of our global customers, ensuring Biognosys remains at the forefront of proteomics advancements.
Lidia Novak, CFA
Chief Financial Officer
Lidia joined Biognosys as CFO in 2018 and is in charge of finance functions including assessment of strategic initiatives and relations with existing and potential investors.
Lukas Reiter, PhD
Chief Technology Officer
Lukas joined Biognosys among the first employees in 2010. As CTO, he oversees research as well as product and workflow development. He has authored key publications in computational proteomics and is a co-inventor of the SWATH technology.
Jakob Vowinckel, PhD
Chief Officer of Scientific Operations
Jakob has a strong track record at Biognosys since 2016, driving innovation and excellence for contract research. As Chief Officer of Scientific Operations, he oversees the company’s global contract research activities that provide valuable data insights for life science research and drug development.
Commercial Leadership
Donna Earley, PhD
VP, Global Service Sales
Donna is a seasoned professional in global sales and account management, with a proven track record at leading life science companies, including Bruker, Thermo Fisher Scientific, and Waters. As VP of Global Service Sales at Biognosys, Donna and her team help biopharma and biotech customers advance their research with our CRO services.
Sira Echevarría Zomeño, PhD
VP, Business Development, Software & Kits
Sira is responsible for the business development and sales of Biognosys’ software and kits. Her team is committed to enabling researchers and mass spectrometry users to apply state-of-the-art proteomics technologies to their research.
Amaury Lachaud, PhD
Head of Sales and Business Development, Europe & Asia
Amaury joined Biognosys in 2020 and leads our services business development and sales team in Europe and Asia. He brings over 13 years of experience in life science and human diagnostic industry, primarily in sales leadership and business unit management roles.
Yves Serroen, MBA
Head of Marketing and Communications
Yves leads the marketing and communications team at Biognosys, which is focused on raising awareness and adoption of Biognosys’ next-generation proteomics platforms and solutions across the services, software and kits markets.
Scientific Advisory Board
Prof. Dr. Ruedi Aebersold
Ruedi, a co-founder of Biognosys, is one of the pioneers in the field of proteomics. He serves on the Scientific Advisory Committees of numerous academic and private-sector research organizations and is a member of several editorial boards in the fields of protein science, genomics, and proteomics.
Johan, Associate Professor at the University of Lund, Sweden, obtained his PhD in a collaboration between Lund University and AstraZeneca R&D Lund. In 2001 he co-founded Ludesi AB. In 2003, Johan joined the Institute for Systems Biology in Seattle, and in 2004, he transferred to the Aebersold lab at the ETH Zurich, where he was involved in the development and application of targeted proteomics technologies and co-founded Biognosys.
Paola obtained her PhD from the University of Padova. In 2006, she joined Prof. Ruedi Aebersold’s group at ETH Zurich, where her research received the ETH Latsis Prize 2011. At the beginning of 2011, she started her own research group and in 2017 she was appointed professor at the Institute of Molecular Systems Biology at ETH Zurich.